4 completed. 4 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 4 |
| Phase 2 | 1 | Completed 1 |
Follow David Bartlett: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| αDC1 Vaccine + Chemokine Modulatory Regimen (CKM) as Adjuvant Treatment of Peritoneal Surface Malignancies DC vaccine, Celecoxib, Interferon Alfa-2b - Malignant Neoplasm of Pancreas Metastatic to Peritoneal Surface, Malignant Peritoneal Mesothelioma | Phase 1 / Phase 2 | Completed | David Bartlett | 64 | 2014-07-01 | 2020-07-20 |
| Safety Study of Modified Vaccinia Virus to Cancer Vaccinia virus (vvDD-CDSR) - Melanoma, Breast Cancer | Phase 1 | Completed | David Bartlett | 26 | 2008-05-01 | 2015-12-28 |
| Safety Study of Oxaliplatin and 5-fluorouracil Followed by FUDR for Unresectable Colorectal Liver Metastases Drug: 5-FU, Drug: Oxaliplatin - Colorectal Liver Metastases | Phase 1 | Completed | David Bartlett | 14 | 2007-07-01 | 2015-12-28 |
| Isolated Liver Perfusion With Oxaliplatin Oxaliplatin - Unresectable Colorectal Liver Metastases | Phase 1 | Completed | David Bartlett | 10 | 2003-05-01 | 2017-12-20 |
Neoplasms (2) · Adenocarcinoma (1) · Breast Neoplasms (1) · Colorectal Neoplasms (1) · Liver Neoplasms (1) · Melanoma (1) · Neoplasm Metastasis (1) · Neoplasms, Squamous Cell (1) · Peritoneal Neoplasms (1) · Vaccinia (1) · Virus Diseases (1)
Oxaliplatin (2) · Acids (1) · AlkB Homolog 2, Alpha-Ketoglutarate-Dependent Dioxygenase (1) · Celecoxib (1) · Fluorouracil (1) · Interferon alpha-2 (1) · Introns (1) · lentiviral minigene vaccine of COVID-19 coronavirus (1) · poly(I).poly(c12,U) (1)
United States (4)
David L Bartlett, M.D. (1) · David L Bartlett, MD (1) · Herbert J. Zeh, MD (1) · Herbert J. Zeh, MD, PhD (1)
P01CA132714 (1), R21CA115059 (1)